CABA
Price
$4.25
Change
-$0.20 (-4.48%)
Updated
Nov 12, 04:01 PM (EDT)
121 days until earnings call
ENTO
Price
$0.62
Change
-$0.02 (-3.12%)
Updated
Nov 12, 03:07 PM (EDT)
Ad is loading...

CABA vs ENTO

Header iconCABA vs ENTO Comparison
Open Charts CABA vs ENTOBanner chart's image
Cabaletta Bio
Price$4.25
Change-$0.20 (-4.48%)
Volume$100
CapitalizationN/A
Entero Therapeutics
Price$0.62
Change-$0.02 (-3.12%)
Volume$900
CapitalizationN/A
CABA vs ENTO Comparison Chart
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ENTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CABA vs. ENTO commentary
Nov 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and ENTO is a Hold.

COMPARISON
Comparison
Nov 12, 2024
Stock price -- (CABA: $4.46 vs. ENTO: $0.64)
Brand notoriety: CABA and ENTO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 79% vs. ENTO: 10%
Market capitalization -- CABA: $217.87M vs. ENTO: $3.03M
CABA [@Biotechnology] is valued at $217.87M. ENTO’s [@Biotechnology] market capitalization is $3.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $476.71B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileENTO’s FA Score has 1 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • ENTO’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTO is a better buy in the long-term than CABA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 5 TA indicator(s) are bullish while ENTO’s TA Score has 4 bullish TA indicator(s).

  • CABA’s TA Score: 5 bullish, 2 bearish.
  • ENTO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CABA is a better buy in the short-term than ENTO.

Price Growth

CABA (@Biotechnology) experienced а +11.50% price change this week, while ENTO (@Biotechnology) price change was -5.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.23%. For the same industry, the average monthly price growth was +11.37%, and the average quarterly price growth was +7.39%.

Reported Earning Dates

CABA is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+1.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($218M) has a higher market cap than ENTO($3.03M). CABA YTD gains are higher at: -80.352 vs. ENTO (-84.845). ENTO has higher annual earnings (EBITDA): -20.9M vs. CABA (-98.61M). CABA has more cash in the bank: 203M vs. ENTO (11.4M). ENTO has less debt than CABA: ENTO (6.98M) vs CABA (7.4M). CABA (0) and ENTO (0) have equivalent revenues.
CABAENTOCABA / ENTO
Capitalization218M3.03M7,204%
EBITDA-98.61M-20.9M472%
Gain YTD-80.352-84.84595%
P/E RatioN/A0.05-
Revenue00-
Total Cash203M11.4M1,781%
Total Debt7.4M6.98M106%
FUNDAMENTALS RATINGS
ENTO: Fundamental Ratings
ENTO
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABAENTO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
CABA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ENTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSMVX421.206.47
+1.56%
Vanguard S&P Small-Cap 600 Val Idx Instl
HQISX22.900.10
+0.44%
Hartford Equity Income R4
HFERX46.440.18
+0.39%
Janus Henderson European Focus N
FGETX25.430.03
+0.12%
Fidelity Advisor Glbl Capital Apprec M
PHSWX9.06-0.06
-0.66%
Parvin Hedged Equity Solari World

ENTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTO has been loosely correlated with IVVD. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTO jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTO
1D Price
Change %
ENTO100%
-7.49%
IVVD - ENTO
60%
Loosely correlated
+1.25%
RLMD - ENTO
36%
Loosely correlated
-0.91%
CABA - ENTO
35%
Loosely correlated
-0.67%
IMMP - ENTO
29%
Poorly correlated
+6.85%
MEOBF - ENTO
24%
Poorly correlated
+8.79%
More